Mon 06 May
|Video available ON-DEMAND - LINK BELOW
Bryan Bell: Towards integrating immunotherapy into the treatment of locally advanced HNSCC
Dr. Bell is in developing new approaches to improve the outcome of surgery for the treatment of head and neck cancer. His work has been published in more than 150 scientific articles. He is co-author of two major textbooks, including "Oral, Head and Neck Oncology and Reconstructive Surgery".
Time & Location
06 May 2024, 09:30
Video available ON-DEMAND - LINK BELOW
About the event
Towards Integrating Immunotherapy into the Treatment of Locally Advanced HNSCC is an advanced clinical and scientific session led by Dr. Bryan Bell, focusing on the evolving role of immunotherapy in the multidisciplinary management of locally advanced head and neck squamous cell carcinoma (HNSCC). This talk provides a current overview of the underlying immunobiology of HNSCC, the rationale for incorporating immune-based treatments alongside surgery, radiation, and chemotherapy, and the latest clinical trial evidence supporting the use of immune checkpoint inhibitors and other immunomodulatory approaches. Participants will gain insights into patient selection, biomarkers of response, strategies to overcome resistance, and the challenges and opportunities in optimizing treatment sequencing and combinations to improve survival and quality of life for patients with advanced disease. The session bridges foundational science with real-world clinical application, highlighting emerging trends and future directions in immuno-oncology for head and neck cancers.
The Video is Now Available On Demand
SPEAKER: Dr. Bryan Bell, MD DDS FACS FRCS(Ed) is globally known head and neck cancer surgeon and researcher. His work has been published in more than 150 scientific articles and book chapters. In addition, he is co-author of two major textbooks, including "Oral, Head and Neck Oncology and Reconstructive Surgery".
His clinical practice is focused on the comprehensive surgical management of patients with head and neck cancer, including tumors of the oral cavity, oropharynx, larynx, thyroid and skull base. Along with his clinical practice, Dr. Bell currently holds a number of leadership positions. He is the Physician Executive and Director, Division of Surgical Oncology, Radiation Oncology, and Clinical Programs for Providence Cancer Institute Oregon. In addition, Dr. Bell is the Medical Director of the Providence Head and Neck Cancer Program, and Member and Director of Surgical Oncology Research at the Earle A. Chiles Research Institute in the Robert W. Franz Cancer Center, a division of the Providence Cancer Institute. Dr. Bell provides vision, leadership, strategy and oversight for all clinical oncology programs and surgical oncology research throughout the Oregon region.
MODERATOR: Anastasiya Quimby MD, DDS, Director of the Multidisciplinary Head and Neck Tumor Board, Good Samaritan Hospital in West Palm Beach, FL, and the Founder of AQ Surgery: Head and Neck and Microvascular Surgery Institute.
ONLINE LIVE EVENT
Palo Alto: Monday, May 6, 2024 at 9:30 am
Mexico City: Monday, May 6, 2024 at 10:30 am
New York: Monday, May 6, 2024 at 12:30 pm
Rio de Janeiro: Monday, May 6, 2024 at 1:30 pm
London: Monday, May 6, 2024 at 5:30 pm
Berlin: Monday, May 6, 2024 at 6:30 pm
Johannesburg: Monday, May 6, 2024 at 6:30 pm
Cairo: Monday, May 6, 2024 at 7:30 pm
Dubai: Monday, May 6, 2024 at 8:30 pm
Islamabad: Monday, May 6, 2024 at 9:30 pm
New Delhi: Monday, May 6, 2024 at 10:00 pm
Manila: Tuesday, May 7, 2024 at 12:30 am
LANGUAGE: The event language is English.
CE ACCREDITATION : surgeON is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. surgeON designates this activity for 1 credit hour of continuing education credits.
DECLARATION : In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.